Page last updated: 2024-08-23

idarubicin and Benign Neoplasms

idarubicin has been researched along with Benign Neoplasms in 37 studies

Research

Studies (37)

Timeframe	Studies, this research(%)	All Research%
pre-1990	12 (32.43)	18.7374
1990's	15 (40.54)	18.2507
2000's	5 (13.51)	29.6817
2010's	1 (2.70)	24.3611
2020's	4 (10.81)	2.80

Authors

Authors	Studies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Amin Hashemipour, SM; Hosseinpour, H; Keshavarzian, E; Khamas, SS; Kogani, M; Moazen, M; Mortazavizadeh, SM; Motevalipoor, AF; Sadighpour, T; Soltani, M; Valizadeh, R	1
Hiraku, Y; Ikemura, K; Imai, M; Kawanishi, S; Kitamura, Y; Maeda, T; Miyazawa, D; Mizutani, H; Ohta, K; Sakanashi, M; Shiga, C; Tahira, T	1
Haemmerich, D; Houtsmuller, AB; Liu, H; Lu, T; Seynhaeve, ALB; Ten Hagen, TLM; van Rhoon, GC	1
Mansouri, K; Mousavi, A; Rafipour, R	1
Lu, SX	1
Horton, D; Khare, A	1
Bijnens, B; Claus, P; D'hooge, J; Eyskens, B; Ganame, J; Gewillig, M; Mertens, L; Renard, M; Sutherland, GR; Uyttebroeck, A	1
Baratz, R; Berman, E; Casper, ES; Gralla, RJ; Howard, J; Leyland-Jones, B; Williams, L; Wittes, RE; Young, CW	1
Bonadonna, G; Bonfante, V; Ferrari, L; Villani, F	1
Cavalli, F; Kaplan, S; Pacciarini, MA; Sessa, C; Tamassia, V; Willems, Y	1
Cavalli, F; Kaplan, S; Martini, A; Togni, P; Varini, M	1
Cotter, SM; L'Heureux, DA; Moore, AS; Rand, WM; Ruslander, D	1
Mehta, J; Philpott, N; Powles, R; Treleaven, J	1
de Valeriola, DL; Lasota, WS; Piccart, MJ	1
Goebel, M	1
Hegewisch-Becker, S	1
Borchmann, P; Engert, A; Hübel, K; Schnell, R	1
Lichtman, SM; Skirvin, JA	1
Conte, P; Danesi, R; Del Tacca, M; Fogli, S; Gennari, A	1
de Valeriola, D; Piccart, MJ; Tomiak, E	1
Cersosimo, RJ	1
Camaggi, CM; Carisi, P; Efthymiopoulos, C; Guaraldi, M; Martoni, A; Pannuti, F; Strocchi, E; Strolin-Benedetti, M; Tononi, A	1
Brown, TD; Burris, HA; Havlin, KA; O'Rourke, TJ; Rodriguez, GI; Wall, JG; Weiss, GR	1
Faulds, D; Hollingshead, LM	1
Green, MD; Muggia, FM	1
Fields, SM; Koeller, JM	1
Fontaine, B; Gupta, S; Maroun, JA; Perrault, DJ; Robillard, L; Stewart, DJ; Verma, S; Young, V	1
D'Incalci, M; Erranti, D; Freshi, A; Tirelli, U; Zanette, L; Zucchetti, M	1
Comazzi, R; Crippa, F; Galimberti, M; Villani, F	1
Andersen, E; Dalmark, M; Elbaek, K; Krarup-Hansen, A; Rasmussen, SN	1
Beer, M; Crespeigne, N; Dodion, P; Finet, C; Kenis, Y; Nicaise, C; Rozencweig, M	1
Gillies, HC; Harper, PG; Herriott, D; Liang, R; Ohashi, K; Rogers, HJ	1
Bacha, DM; Dantis, E; Hancock, C; Luks, E; Meyers, P; Mondora, A; Steinherz, L; Steinherz, P; Tan, CT; Winick, N	1
Ganzina, F; Hurteloup, P	1
Kavanagh, JJ; Krakoff, IH; Savaraj, N; Yeung, KY	1
Ogawa, M	1

Reviews

15 review(s) available for idarubicin and Benign Neoplasms

Article	Year
Prophylactic Agents for Preventing Cardiotoxicity Induced Following Anticancer Agents: A Systematic Review and Meta-Analysis of Clinical Trials. Reviews on recent clinical trials, 2023, Volume: 18, Issue:2 Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Cardiotoxicity; Dexrazoxane; Humans; Idarubicin; Neoplasms	2023
[Tumor stem cells and their impact on the concept of cancer treatment]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Humans; Idarubicin; Leupeptins; Neoplasms; Neoplastic Stem Cells	2010
Potential role of oral anthracyclines in older patients with cancer. Drugs & aging, 1994, Volume: 4, Issue:5 Topics: Administration, Oral; Aged; Biological Availability; Clinical Trials as Topic; Half-Life; Humans; Idarubicin; Intestinal Absorption; Leukopenia; Menogaril; Metabolic Clearance Rate; Neoplasms	1994
Oral idarubicin--an anthracycline derivative with unique properties. Annals of hematology, 1993, Volume: 66, Issue:1 Topics: Administration, Oral; Animals; Humans; Idarubicin; Mice; Neoplasms	1993
MDR1 reversal: criteria for clinical trials designed to overcome the multidrug resistance phenotype. Leukemia, 1996, Volume: 10 Suppl 3 Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clinical Trials as Topic; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Idarubicin; Immunologic Factors; Neoplasms; Phenotype; Research Design; Time Factors; Up-Regulation	1996
Idarubicin: a brief overview on pharmacology and clinical use. International journal of clinical pharmacology and therapeutics, 1997, Volume: 35, Issue:2 Topics: Animals; Antibiotics, Antineoplastic; Drug Resistance, Neoplasm; Humans; Idarubicin; Neoplasms; Neoplasms, Experimental	1997
Pharmacokinetic considerations of oral chemotherapy in elderly patients with cancer. Drugs & aging, 2002, Volume: 19, Issue:1 Topics: Administration, Oral; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Complementary Therapies; Cytochrome P-450 Enzyme System; Dacarbazine; Etoposide; Humans; Idarubicin; Neoplasms; Tamoxifen; Temozolomide; Thalidomide; Topotecan	2002
Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs. Clinical pharmacokinetics, 2002, Volume: 41, Issue:6 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Area Under Curve; Doxorubicin; Epirubicin; Half-Life; Humans; Idarubicin; Metabolic Clearance Rate; Neoplasms; Prodrugs; Structure-Activity Relationship	2002
Idarubicin: an anthracycline antineoplastic agent. Clinical pharmacy, 1992, Volume: 11, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Breast Neoplasms; Cytarabine; Drug Labeling; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1992
New anticancer agents. Cancer chemotherapy and biological response modifiers, 1991, Volume: 12 Topics: Alkaloids; Animals; Antineoplastic Agents; Azacitidine; Biphenyl Compounds; Chrysenes; Deoxycytidine; Echinomycin; Epirubicin; Etanidazole; Flavonoids; Gemcitabine; Guanidines; Humans; Idarubicin; Menogaril; Mitoguazone; Neoplasms; Nitroimidazoles; Nogalamycin; Organoplatinum Compounds; Paclitaxel; Pentostatin; Polymers; Propylene Glycols; Ribavirin; Sulfonylurea Compounds; Trimetrexate; Vidarabine Phosphate	1991
Idarubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer. Drugs, 1991, Volume: 42, Issue:4 Topics: Animals; Humans; Idarubicin; Neoplasms; Neoplasms, Experimental	1991
New anthracycline antitumor antibiotics. Critical reviews in oncology/hematology, 1991, Volume: 11, Issue:1 Topics: Aclarubicin; Antibiotics, Antineoplastic; Cardiomyopathies; Carubicin; Doxorubicin; Drug Resistance; Epirubicin; Humans; Idarubicin; Menogaril; Molecular Structure; Neoplasms; Nogalamycin	1991
Idarubicin: a second-generation anthracycline. DICP : the annals of pharmacotherapy, 1991, Volume: 25, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Drug Evaluation; Humans; Idarubicin; Leukemia; Neoplasms; Remission Induction	1991
Clinical studies with new anthracyclines: epirubicin, idarubicin, esorubicin. Drugs under experimental and clinical research, 1986, Volume: 12, Issue:1-3 Topics: Antibiotics, Antineoplastic; Bone Marrow; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Drug Evaluation; Epirubicin; Heart; Humans; Idarubicin; Neoplasms	1986
[Current status of clinical results of new antitumor drugs]. Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:2 Topics: Aminoacridines; Amsacrine; Anthracyclines; Anthraquinones; Antibiotics, Antineoplastic; Antineoplastic Agents; Aziridines; Benzoquinones; Carboplatin; Carubicin; Cisplatin; Daunorubicin; Doxorubicin; Eflornithine; Epirubicin; Humans; Idarubicin; Mitoxantrone; Naphthacenes; Neoplasms; Organoplatinum Compounds; Ornithine; Ribavirin	1985

Trials

4 trial(s) available for idarubicin and Benign Neoplasms

Article	Year
Idarubicin, high-dose cytarabine and etoposide for remission induction in therapy-related acute myeloid leukemia. Leukemia & lymphoma, 1994, Volume: 15, Issue:1-2 Topics: Acute Disease; Adult; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Bone Marrow Diseases; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Etoposide; Female; Gastrointestinal Diseases; Humans; Idarubicin; Leukemia, Myeloid; Leukemia, Radiation-Induced; Male; Middle Aged; Neoplasms; Prospective Studies; Radiotherapy; Remission Induction; Salvage Therapy; Treatment Outcome	1994
Idarubicin metabolism and pharmacokinetics after intravenous and oral administration in cancer patients: a crossover study. Cancer chemotherapy and pharmacology, 1992, Volume: 30, Issue:4 Topics: Administration, Oral; Biological Availability; Daunorubicin; Glycosylation; Humans; Idarubicin; Infusions, Intravenous; Kidney; Kidney Diseases; Liver Neoplasms; Neoplasms	1992
New anthracycline antitumor antibiotics. Critical reviews in oncology/hematology, 1991, Volume: 11, Issue:1 Topics: Aclarubicin; Antibiotics, Antineoplastic; Cardiomyopathies; Carubicin; Doxorubicin; Drug Resistance; Epirubicin; Humans; Idarubicin; Menogaril; Molecular Structure; Neoplasms; Nogalamycin	1991
Clinical studies with new anthracyclines: epirubicin, idarubicin, esorubicin. Drugs under experimental and clinical research, 1986, Volume: 12, Issue:1-3 Topics: Antibiotics, Antineoplastic; Bone Marrow; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Drug Evaluation; Epirubicin; Heart; Humans; Idarubicin; Neoplasms	1986

Other Studies

20 other study(ies) available for idarubicin and Benign Neoplasms

Article	Year
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Idarubicin, an Anthracycline, Induces Oxidative DNA Damage in the Presence of Copper (II). Anticancer research, 2020, Volume: 40, Issue:10 Topics: Anthracyclines; Copper; DNA Damage; Humans; Idarubicin; Neoplasms; Oxidative Stress; Reactive Oxygen Species; Superoxide Dismutase	2020
Externally triggered smart drug delivery system encapsulating idarubicin shows superior kinetics and enhances tumoral drug uptake and response. Theranostics, 2021, Volume: 11, Issue:12 Topics: Animals; Antibiotics, Antineoplastic; Biological Transport; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Drug Liberation; Humans; Hydrogen-Ion Concentration; Hyperthermia, Induced; Idarubicin; Kinetics; Mice; Nanoparticles; Neoplasms; Tissue Distribution	2021
Apoferritin nanocages for targeted delivery of idarubicin against breast cancer cells. Biotechnology and applied biochemistry, 2022, Volume: 69, Issue:3 Topics: Animals; Antineoplastic Agents; Apoferritins; Drug Delivery Systems; Horses; Idarubicin; Nanotechnology; Neoplasms	2022
Anthracycline glycosides of 2,6-dideoxy-2-fluoro-alpha-L-talopyranose. Carbohydrate research, 2006, Nov-27, Volume: 341, Issue:16 Topics: Anthracyclines; Antineoplastic Agents; Cell Line, Tumor; Doxorubicin; Glycosides; Humans; Idarubicin; Neoplasms	2006
Acute cardiac functional and morphological changes after Anthracycline infusions in children. The American journal of cardiology, 2007, Apr-01, Volume: 99, Issue:7 Topics: Adolescent; Anthracyclines; Antibiotics, Antineoplastic; Blood Flow Velocity; Blood Pressure; Child; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Echocardiography, Doppler; Female; Heart Rate; Humans; Idarubicin; Infusions, Intravenous; Male; Myocardial Contraction; Neoplasms; Observer Variation; Prospective Studies; Reproducibility of Results; Research Design; Stroke Volume; Treatment Outcome; Ventricular Function, Left	2007
Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer. Cancer research, 1983, Volume: 43, Issue:12 Pt 1 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Immunosuppression Therapy; Injections, Intravenous; Kinetics; Male; Middle Aged; Neoplasms	1983
Phase I study of 4-demethoxydaunorubicin. Investigational new drugs, 1983, Volume: 1, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Child; Child, Preschool; Daunorubicin; Digestive System; Drug Evaluation; Female; Humans; Idarubicin; Injections, Intravenous; Leukopenia; Male; Middle Aged; Neoplasms; Thrombocytopenia	1983
Phase I trial of 4-demethoxydaunorubicin (idarubicin) with single oral doses. Investigational new drugs, 1984, Volume: 2, Issue:3 Topics: Administration, Oral; Aged; Antineoplastic Agents; Biological Availability; Blood; Daunorubicin; Drug Evaluation; Female; Heart; Humans; Idarubicin; Male; Middle Aged; Neoplasms	1984
Phase I trial of 4-demethoxydaunorubicin with single i.v. doses. European journal of cancer & clinical oncology, 1982, Volume: 18, Issue:12 Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow Diseases; Daunorubicin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Humans; Idarubicin; Kinetics; Male; Middle Aged; Neoplasms	1982
Efficacy of, and toxicoses associated with, oral idarubicin administration in cats with neoplasia. Journal of the American Veterinary Medical Association, 1995, May-15, Volume: 206, Issue:10 Topics: Administration, Oral; Animals; Anorexia; Cat Diseases; Cats; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Idarubicin; Leukopenia; Lymphoma; Male; Neoplasms; Vomiting	1995
Anthracyclines active via the oral route: luxury or necessity? Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3, Issue:3 Topics: Administration, Oral; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Female; Humans; Idarubicin; Menogaril; Neoplasms; Nogalamycin	1992
Phase I study of idarubicin administered orally on a daily x 3 schedule. Investigational new drugs, 1990, Volume: 8, Issue:3 Topics: Administration, Oral; Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Humans; Idarubicin; Male; Neoplasms	1990
Pharmacokinetics of 4-demethoxydaunorubicin in cancer patients. Cancer chemotherapy and pharmacology, 1990, Volume: 25, Issue:6 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Biological Availability; Daunorubicin; Female; Half-Life; Humans; Idarubicin; Injections, Intravenous; Male; Middle Aged; Neoplasms	1990
Evaluation of cardiac toxicity of idarubicin (4-demethoxydaunorubicin). European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:1 Topics: Administration, Oral; Adolescent; Adult; Aged; Blood Pressure; Child; Drug Evaluation; Electrocardiography; Female; Heart; Heart Rate; Humans; Idarubicin; Injections, Intravenous; Male; Middle Aged; Neoplasms; Stroke Volume; Systole	1989
Phase I study of 4-demethoxydaunorubicin by oral route in patients with advanced cancer. Acta oncologica (Stockholm, Sweden), 1988, Volume: 27, Issue:5 Topics: Administration, Oral; Adult; Aged; Drug Evaluation; Female; Humans; Idarubicin; Male; Middle Aged; Neoplasms	1988
Phase I study of oral idarubicin given with a weekly schedule. Investigational new drugs, 1986, Volume: 4, Issue:1 Topics: Administration, Oral; Adult; Aged; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Idarubicin; Leukopenia; Male; Middle Aged; Neoplasms; Risk; Thrombocytopenia	1986
Pharmacokinetics of idarubicin (4-demethoxydaunorubicin; IMI-30; NSC 256439) following intravenous and oral administration in patients with advanced cancer. British journal of clinical pharmacology, 1987, Volume: 23, Issue:3 Topics: Administration, Oral; Adult; Aged; Biological Availability; Daunorubicin; Female; Half-Life; Humans; Idarubicin; Infusions, Intravenous; Kinetics; Male; Middle Aged; Neoplasms	1987
Phase I and clinical pharmacological study of 4-demethoxydaunorubicin (idarubicin) in children with advanced cancer. Cancer research, 1987, Jun-01, Volume: 47, Issue:11 Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Daunorubicin; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Idarubicin; Infant; Leukemia; Metabolic Clearance Rate; Neoplasms	1987
Phase I clinical evaluation of oral and intravenous 4-demethoxydaunorubicin. European journal of cancer & clinical oncology, 1985, Volume: 21, Issue:10 Topics: Administration, Oral; Adult; Aged; Agranulocytosis; Antineoplastic Agents; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Injections, Intravenous; Male; Middle Aged; Neoplasms; Thrombocytopenia	1985